tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Revenue

Compare
1,440 Followers

Allogene Therapeutics Revenue

Allogene Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with 100.00%. This bring the company's revenue in the last twelve months to -22.00K, Increased -Infinity%. In the fiscal year ending Dec 31, 2024, Allogene Therapeutics had annual revenue of 22.00K with -76.84% growth.
Revenue (ttm)
-22.00K
Revenue Growth
-100.00%
P/S Ratio
13620.96
Revenue/Employee
$97
Employees
226
Market Cap
$299.66M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
22.00K-73.00K-76.84%
Dec 31, 2023
95.00K-61.00K-39.10%
Dec 31, 2022
156.00K-113.93M-99.86%
Dec 31, 2021
114.09M+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis